ICOPE Program Feasibility in the Management of Myeloma Patients
NCT06247189 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-12-22
Summary
This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.
Conditions
Interventions
- OTHER
-
ICOPE Monitoring
At inclusion set up of the ICOPE monitor program on the patient's device and evaluation (all steps) of ICOPE Monitor program. Monthly, re-evaluation of the patient (Step 1 and others if necessary ) according to the ICOPE Monitor program
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Principal Investigators
-
Gilles BOURGADE · University Hospital, Toulouse
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-03
- Primary Completion
- 2026-12-03
- Completion
- 2026-12-30
Countries
- France
Study Locations
More Related Trials
-
REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs
NCT05223413 ·Status: RECRUITING ·Phase: NA
-
Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy
NCT05101759 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
NCT07082686 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)
NCT01553786 ·Status: COMPLETED ·Phase: PHASE2
-
R-CHOP14 or R-CHOP21 &Consolidation PET-Oriented Radiotherapy (RT) in DLBCL Patients
NCT03364439 ·Status: COMPLETED ·Phase: PHASE2
-
Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma
NCT00774826 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma
NCT00906841 ·Status: TERMINATED ·Phase: PHASE2
-
The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19
NCT04746092 ·Status: UNKNOWN
-
R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL
NCT01865110 ·Status: COMPLETED ·Phase: PHASE3
-
Secondary Prognostic Index in RefrActory Lymphoma
NCT04804865 ·Status: UNKNOWN
-
Indolent Non Follicular Lymphomas Prognostic Project
NCT02904577 ·Status: COMPLETED
-
Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy
NCT06422247 ·Status: COMPLETED
-
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL
NCT00209209 ·Status: UNKNOWN ·Phase: PHASE3
-
Intensification Therapy of Mature B-ALL, Burkitt and Burkitt Like and Other High Grade Non-Hodgkin's Lymphoma in Adults
NCT00797810 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma
NCT00435955 ·Status: UNKNOWN ·Phase: PHASE3
-
TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma
NCT02927964 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
NCT02559583 ·Status: COMPLETED
-
Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)
NCT00505232 ·Status: COMPLETED ·Phase: PHASE2
-
Maintenance Treatment Versus Observation in Elderly Patients With PCNS Lymphoma
NCT02313389 ·Status: UNKNOWN ·Phase: PHASE3
-
Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas
NCT00869284 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of SyB L-0501 in Combination With Rituximab in Patients With Untreated, Low-grade B Cell Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
NCT01718691 ·Status: COMPLETED ·Phase: PHASE2
-
Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?
NCT03681938 ·Status: UNKNOWN
-
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
NCT05429918 ·Status: UNKNOWN
-
Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment
NCT01521689 ·Status: UNKNOWN ·Phase: PHASE2
-
Quality of Life in Lymphoma Patients One Year Post-chemotherapy
NCT04187118 ·Status: UNKNOWN